CellaVision AB (publ) (CLVSF)
OTCMKTS · Delayed Price · Currency is USD
15.85
+0.40 (2.59%)
At close: Feb 5, 2026
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of $404.89 million as of February 12, 2026. Its market cap has decreased by -14.25% in one year.
Market Cap
404.89M
Enterprise Value
390.12M
Revenue
79.43M
Ranking
n/a
PE Ratio
25.20
Stock Price
$15.85
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 54.35M to 404.89M, an increase of 644.96%. That is a compound annual growth rate of 11.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 404.89M | -0.75% |
| Dec 30, 2025 | 407.95M | -13.15% |
| Dec 30, 2024 | 469.69M | -6.32% |
| Dec 29, 2023 | 501.37M | -4.32% |
| Dec 30, 2022 | 523.98M | -38.89% |
| Dec 30, 2021 | 857.50M | -4.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 414.06M |
| Tian'an Technology Group | 182.07M |
| Zomedica | 127.39M |
| Positron | 68.49M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 55.00M |
| Guided Therapeutics | 33.69M |
| Vivos | 33.66M |